690,000 Units REPROS THERAPEUTICS INC. Each Unit consisting of 4 Shares of Common Stock and 3 Series A Warrants and 2.45 Series B Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • February 9th, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 9th, 2011 Company Industry JurisdictionBased on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:
SERIES B WARRANT AGREEMENTSeries B Warrant Agreement • February 9th, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 9th, 2011 Company Industry Jurisdiction
SERIES A WARRANT AGREEMENTSeries a Warrant Agreement • February 9th, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 9th, 2011 Company Industry Jurisdiction